1183 related articles for article (PubMed ID: 14557380)
1. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
2. Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and heroin.
Stevenson GW; Folk JE; Rice KC; Negus SS
J Pharmacol Exp Ther; 2005 Jul; 314(1):221-31. PubMed ID: 15792997
[TBL] [Abstract][Full Text] [Related]
3. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys.
Brandt MR; Negus SS; Mello NK; Furness MS; Zhang X; Rice KC
J Pharmacol Exp Ther; 1999 Sep; 290(3):1157-64. PubMed ID: 10454490
[TBL] [Abstract][Full Text] [Related]
5. Selective enhancement of fentanyl-induced antinociception by the delta agonist SNC162 but not by ketamine in rhesus monkeys: Further evidence supportive of delta agonists as candidate adjuncts to mu opioid analgesics.
Banks ML; Folk JE; Rice KC; Negus SS
Pharmacol Biochem Behav; 2010 Dec; 97(2):205-12. PubMed ID: 20678514
[TBL] [Abstract][Full Text] [Related]
6. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
7. Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation.
Brandt MR; Furness MS; Rice KC; Fischer BD; Negus SS
J Pharmacol Exp Ther; 2001 Nov; 299(2):629-37. PubMed ID: 11602675
[TBL] [Abstract][Full Text] [Related]
8. Micro/kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability.
Negus SS; Schrode K; Stevenson GW
Exp Clin Psychopharmacol; 2008 Oct; 16(5):386-99. PubMed ID: 18837635
[TBL] [Abstract][Full Text] [Related]
9. Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist.
Pakarinen ED; Woods JH; Moerschbaecher JM
J Pharmacol Exp Ther; 1995 Feb; 272(2):552-9. PubMed ID: 7853168
[TBL] [Abstract][Full Text] [Related]
10. Modulation of delta opioid agonist-induced antinociception by repeated morphine pretreatment in rhesus monkeys.
Negus SS; Banks ML; Folk JE; Rice KC
Life Sci; 2010 Mar; 86(11-12):385-92. PubMed ID: 20096291
[TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.
Negus SS; Gatch MB; Mello NK; Zhang X; Rice K
J Pharmacol Exp Ther; 1998 Jul; 286(1):362-75. PubMed ID: 9655881
[TBL] [Abstract][Full Text] [Related]
12. Delta opioid antagonist effects of buprenorphine in rhesus monkeys.
Negus SS; Bidlack JM; Mello NK; Furness MS; Rice KC; Brandt MR
Behav Pharmacol; 2002 Nov; 13(7):557-70. PubMed ID: 12409994
[TBL] [Abstract][Full Text] [Related]
13. Role of delta opioid efficacy as a determinant of mu/delta opioid interactions in rhesus monkeys.
Negus SS; Bear AE; Folk JE; Rice KC
Eur J Pharmacol; 2009 Jan; 602(1):92-100. PubMed ID: 19027735
[TBL] [Abstract][Full Text] [Related]
14. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.
Negus SS; Burke TF; Medzihradsky F; Woods JH
J Pharmacol Exp Ther; 1993 Nov; 267(2):896-903. PubMed ID: 8246165
[TBL] [Abstract][Full Text] [Related]
15. Effects of the delta-opioid agonist SNC80 on the abuse liability of methadone in rhesus monkeys: a behavioral economic analysis.
Banks ML; Roma PG; Folk JE; Rice KC; Negus SS
Psychopharmacology (Berl); 2011 Aug; 216(3):431-9. PubMed ID: 21369752
[TBL] [Abstract][Full Text] [Related]
16. The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
da Fonseca Pacheco D; Klein A; de Castro Perez A; da Fonseca Pacheco CM; de Francischi JN; Duarte ID
Br J Pharmacol; 2008 Jul; 154(5):1143-9. PubMed ID: 18469844
[TBL] [Abstract][Full Text] [Related]
17. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.
Horan P; de Costa BR; Rice KC; Porreca F
J Pharmacol Exp Ther; 1991 Jun; 257(3):1154-61. PubMed ID: 1646325
[TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys.
Negus SS; Butelman ER; Chang KJ; DeCosta B; Winger G; Woods JH
J Pharmacol Exp Ther; 1994 Sep; 270(3):1025-34. PubMed ID: 7932149
[TBL] [Abstract][Full Text] [Related]
19. Effects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.
Gatch MB; Negus SS; Mello NK; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1996 Sep; 278(3):1282-9. PubMed ID: 8819513
[TBL] [Abstract][Full Text] [Related]
20. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]